References
Szurian, K. et al. Rarity among benign gastric tumors: Plexiform fibromyxoma - Report of two cases. World journal of gastroenterology 23, 5817–5822, doi:https://doi.org/10.3748/wjg.v23.i31.5817 (2017).
Miettinen, M., Makhlouf, H. R., Sobin, L. H. & Lasota, J. Plexiform Fibromyxoma: A Distinctive Benign Gastric Antral Neoplasm Not to be Confused With a Myxoid Gist. The American journal of surgical pathology 33, 1624–1632, doi:https://doi.org/10.1097/PAS.0B013E3181AE666A (2009).
Morris, M. W., Sullivan, L., Sawaya, D. E., Steiner, M. A. & Nowicki, M. J. Gastric plexiform fibromyxoma tumor in a child – Case report and review of the literature. Journal of Pediatric Surgery Case Reports Volume 4, Pages 38–41 (2016).
Financial Support
This work was supported by the Society for Surgery of the Alimentary Tract (SSAT) Mentored Research Award (S.B), UC San Diego GIST Research Fund (J.K.S.), NIH K08CA168999 (J.K.S.) and NIH R21CA192072 (J.K.S.).
Author information
Authors and Affiliations
Contributions
SB contributed to the acquisition, analysis, and interpretation of patient data and the drafting of the manuscript. He approves of the final version to be published. He agrees to be accountable for all aspects of the work in ensuring that questions related to any part of the work are appropriately investigated and resolved.
JdlT contributed to the acquisition, analysis, and interpretation of patient data and the drafting of the manuscript. He approves of the final version to be published. He agrees to be accountable for all aspects of the work in ensuring that questions related to any part of the work are appropriately investigated and resolved.
AMB contributed to the acquisition, analysis, and interpretation of patient data and the drafting of the manuscript. He approves of the final version to be published. He agrees to be accountable for all aspects of the work in ensuring that questions related to any part of the work are appropriately investigated and resolved.
AMPT contributed to the acquisition, analysis, and interpretation of patient data and the drafting of the manuscript. He approves of the final version to be published. He agrees to be accountable for all aspects of the work in ensuring that questions related to any part of the work are appropriately investigated and resolved.
TJS contributed to the acquisition, analysis, and interpretation of patient data and the drafting of the manuscript. He approves of the final version to be published. He agrees to be accountable for all aspects of the work in ensuring that questions related to any part of the work are appropriately investigated and resolved.
JKS contributed to the acquisition, analysis, and interpretation of patient data and the drafting of the manuscript. He approves of the final version to be published. He agrees to be accountable for all aspects of the work in ensuring that questions related to any part of the work are appropriately investigated and resolved.
Corresponding author
Ethics declarations
Conflict of Interest
Jason Sicklick receives research funding from Novartis Pharmaceuticals, Amgen Pharmaceuticals, and Foundation Medicine, as well as consultant fees from Biotheranostics. J.K.S. also serves or served as consultant to the following organizations: Grand Rounds (2015–2018) and Loxo Oncology (2017–2018). These disclosures had no impact on any of the work presented in this manuscript. No other authors have any conflict of interests to declare.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Banerjee, S., de la Torre, J., Burgoyne, A.M. et al. Gastric Plexiform Fibromyxoma. J Gastrointest Surg 23, 1936–1939 (2019). https://doi.org/10.1007/s11605-019-04132-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-019-04132-0